1-4 of 4
Margareth Macro
Close
Save search
Sort by
Journal Articles

Risk and Response Adapted Conventional Treatment Strategy in 146 Patients with AL Amyloidosis

Free
Arnaud Jaccard, MD, Frank Bridoux, MD, Estibaliz Lazaro, MD, Olivier Tournilhac, MD, Margareth Macro, MD, Murielle Roussel, MD, Bruno Moulin, MD, Xavier Leleu, MD, Mamoun Did, MD, Sylvain Choquet, MD, Pierre Morel, MD, Bruno Royer, MD, David Lavergne, PhD, Charlotte Rigaud, MD, Jean Paul Fermand, MD
Journal: Blood
Blood (2014) 124 (21): 2131.
https://doi.org/10.1182/blood.V124.21.2131.2131
Published: 2014
Journal Articles

Acquired Von Willebrand Syndrome Associated with B Cell Chronic Lymphoproliferative Disorders. Results from a Prospective Observational Study

Free
Jean Baptiste Rabec, MD, Philippe Gautier, MD, Xavier Troussard, MD PhD, Anne Claire Gac, MD, Sylvain Chantepie, MD, Margareth Macro, MD, Stephane Cheze, MD, Khaled Benabed, MD, Damaj Gandhi, MDPhD, Annie Borel Derlon, MDPhD, Yohann Repesse, PhD
Journal: Blood
Blood (2014) 124 (21): 1509.
https://doi.org/10.1182/blood.V124.21.1509.1509
Published: 2014
Journal Articles

Frontline Therapy with the Ribvd Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final Results of a Prospective Phase II Trial By the Lysa Group

Free
Remy Gressin, MD, Mary Callanan, MD PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Marie Pierre Moles, MD, Guillaume Cartron, MD, Roch Houot, MD PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD PhD, Anne Banos, MD, Christiane Mounier, MD, Jehan Dupuis, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD PhD, Lionel Karlin, Pierre Feugier, MD PhD, Luc Matthieu Fornecker, MD, Cecile Chabrot, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Katell Le Dû, Nadine Morineau, Hacene Zerazhi, MD, Jean Fontan, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MDPhD, Steven Le Gouill, MD PhD, Ghandi Damaj, MD
Journal: Blood
Blood (2014) 124 (21): 148.
https://doi.org/10.1182/blood.V124.21.148.148
Published: 2014
Journal Articles

The Ribvd Regimen (Rituximab IV, Bendamustine IV, Velcade SC, Dexamethasone IV) Offers a High Complete Response Rate In Elderly Patients With Untreated Mantle Cell Lymphoma. Preliminary Results Of The Lysa Trial “Lymphome Du Manteau 2010 SA”

Free
Remy Gressin, MD, Mary Callanan, MD, PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Guillaume Cartron, MD, PhD, Anne Schmitt, MD, Roch Houot, MD, PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD, PhD, Anne Banos, MD, Jehan Dupuis, MD, Christiane Mounier, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD, PhD, Lionel Kardin, MD, Gandhi Damaj, MD, Pierre Feugier, MD, PhD, luc Matthieu Fornacker, MD, Cecile molucon Chabrot, MD, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Philippe Solal-Céligny, MD, Nadine Morineau, MD, Marie Pierre Moles, MD, Hacene Zerazhi, MD, Jean Fontan, MD, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MD PhD, Steven Le Gouill, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 370.
https://doi.org/10.1182/blood.V122.21.370.370
Published: 2013